Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

13 resultsUpdated October 20, 2026
1

Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer

International Journal of Molecular Sciences 21(22) (2020)

Nuri Lee; Min-Jeong Park; Wonkeun Song; Kibum Jeon; Seri Jeong

2

Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells

Cancer Biology & Therapy 19(8) (2018)

Ling Cheng; Ying Tang; Xing Chen; Lei Zhao; Songya Liu; Yanna Ma; Na Wang; Kuangguo Zhou; Jianfeng Zhou; Mi Zhou

3

Association between interleukin‐1 receptor antagonist (IL‐1ra) VNTR, gene polymorphism and breast cancer susceptibility in Iranian population: Experimental and web‐based analysis

International Journal of Immunogenetics 49(4) (2022)

Reza Ibrahimi; Mostafa Ibrahimi; Behzad jamalzei; Mohammad Esmaeil Akbari; Mohsen Navari; Maryam Moossavi; Milad Khorasani

4

Lipotoxicity, neuroinflammation, glial cells and oestrogenic compounds

Journal of Neuroendocrinology 32(1) (2019)

Oscar Hidalgo‐Lanussa; Eliana Baez‐Jurado; Valentina Echeverria; Ghulam Md Ashraf; Amirhossein Sahebkar; Luis Miguel Garcia‐Segura; Roberto C. Melcangi; George E. Barreto

5

The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1)

Cancer Treatment and Research Communications 19 (2019)

Omar Najim; Manon Huizing; Konstantinos Papadimitriou; Xuan Bich Trinh; Patrick Pauwels; Sofie Goethals; Karen Zwaenepoel; Kevin Peterson; Joost Weyler; Sevilay Altintas; Peter van Dam; Wiebren Tjalma

6

Novel Approaches to Immunotherapy in Triple Negative Breast Cancer

International Journal of Cancer Management In Press(In Press) (2018)

Sanaz Tabarestani; Mohammad Esmaeil- Akbari; Saeed Namaki

7

Genomics Role in Cancer Immunosurveillance: Impact on Immunotherapy Response

International Journal of Cancer Management In Press(In Press) (2018)

Sanaz Tabarestani; Mohammad Esmaeil- Akbari; Saeed Namaki

8

Long non-coding RNA GHET1 Is Possibly Involved in the Pathogenesis of a Fraction of Breast Cancers

International Journal of Cancer Management 10(10) (2017)

Shaghayegh Sarrafzadeh; Mohammad Taheri; Lobat Geranpayeh; Somayyeh Ghafouri-Fard; Soudeh Ghafouri-Fard

9

Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis

Frontiers in Oncology 13 (2023)

Omar Najim; Konstantinos Papadimitriou; Glenn Broeckx; Manon Huizing; Wiebren Tjalma

10

Omics Technologies Improving Breast Cancer Research and Diagnostics

International Journal of Molecular Sciences 24(16) (2023)

Arianna Orsini; Chiara Diquigiovanni; Elena Bonora

11

Importance of genetic background of oxysterol signaling in cancer

Biochimie 153 (2018)

P. Holy; A. Kloudova; P. Soucek

12

<p>Personalized medicine in breast cancer: pharmacogenomics approaches</p>

Pharmacogenomics and Personalized Medicine Volume 12 (2019)

Shabnam Jeibouei; Mohammad Esmael Akbari; Alireza Kalbasi; Amir reza Aref; Mohammad Ajoudanian; Alireza Rezvani; Hakimeh Zali